|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | |
| A61K 31/437 | |||
| A61P 1/04 | |||
| A61P 11/06 | |||
| A61P 11/08 |
| (11) | Patento numeris | 1697360 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04809082.3 |
| Europos patento paraiškos padavimo data | 2004-12-16 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-09-06 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-02-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/SE2004/001909 |
| Data | 2004-12-16 |
| (87) | Numeris | WO 2005/058895 |
| Data | 2005-06-30 |
| (30) | Numeris | Data | Šalis |
| 0303451 | 2003-12-18 | SE |
| (72) |
LILLJEQUIST, Lars, SE
LINDKVIST, Maria, SE
NORDBERG, Peter, SE
PETTERSSON, Ursula, SE
SEBHATU, Tesfai, SE
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | NOVEL CRYSTALLINE FORMS OF 2, 3 DIMETHYL-8- (2, 6-DIMETHYLBENZYLAMINO) -N-HYDROXYETHYL-IMIDAZO 1, 2-A PYRIDINE-6-CARBOXAMIDE MESYLATE SALT. |
| NOVEL CRYSTALLINE FORMS OF 2, 3 DIMETHYL-8- (2, 6-DIMETHYLBENZYLAMINO) -N-HYDROXYETHYL-IMIDAZO 1, 2-A PYRIDINE-6-CARBOXAMIDE MESYLATE SALT. |